Ebrahimi et al. [70] investigated a 99mTc-radiolabeled anionic citric acid dendrimer conjugated with a VEGF antagonist peptide for breast cancer imaging and therapy monitoring. This evidence concerns the gene VEGFA and breast carcinoma.